SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Allogene Therapeutics Updates Officer Compensation

Allogene Therapeutics files 8-K on officer compensatory arrangements. The filing discloses changes to executive pay.

ALLO

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.